Recall of Reagent Bond Polymer Refine Red Detection System and ChromoPlex 1 Dual Detection for Bond

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Leica.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2013-08-14
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    The company LEICA and A. Menarini Diagnostics informed users of the removal of seven batches of Bond Polymer Refine RedDetection System reagent and one batch of ChromoPlex 1 Dual Detection for Bond reagent. The users concerned, in France, received the enclosed letters (14/08/2013) (1787 KB). This information is addressed to the directors of health establishments and local correspondents of reactive vigilance for broadcasting to the services concerned.

Device

  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer

Manufacturer